PDLI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PDLI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Retained earnings is the accumulated portion of net income that is not distributed to shareholders. PDL BioPharma's retained earnings for the quarter that ended in Jun. 2020 was $485.49 Mil.
PDL BioPharma's quarterly retained earnings declined from Dec. 2019 ($670.83 Mil) to Mar. 2020 ($621.13 Mil) and declined from Mar. 2020 ($621.13 Mil) to Jun. 2020 ($485.49 Mil).
PDL BioPharma's annual retained earnings declined from Dec. 2017 ($945.61 Mil) to Dec. 2018 ($828.55 Mil) and declined from Dec. 2018 ($828.55 Mil) to Dec. 2019 ($670.83 Mil).
The historical data trend for PDL BioPharma's Retained Earnings can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PDL BioPharma Annual Data | |||||||||||||||||||||
Trend | Dec10 | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | |||||||||||
Retained Earnings | Get a 7-Day Free Trial | 810.04 | 857.12 | 945.61 | 828.55 | 670.83 |
PDL BioPharma Quarterly Data | ||||||||||||||||||||
Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | |
Retained Earnings | Get a 7-Day Free Trial | 759.08 | 736.70 | 670.83 | 621.13 | 485.49 |
Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.
Of course, if a company loses, it is called retained losses, or accumulated losses.
PDL BioPharma (NAS:PDLI) Retained Earnings Explanation
Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.
For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.
If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.
Of course, many companies with negative retained earnings have indeed lost money in the past.
Retained Earnings: Warren Buffett's Secret.
One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.
If the company loses more than it has accumulated, retained earnings is negative.
If a company isn't adding to its retained earnings, it isn't growing its net worth.
Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.
Microsoft is negative because it chose to buyback stock and pay dividends.
The more earnings retained, the faster it grows and increases growth rate for future earnings.
David W Gryska | director | 749 N MARY AVE, SUNNYVALE CA 94085 |
John Peter Mclaughlin | director | C/O PDL BIOPHARMA, INC., 932 SOUTHWOOD BOULEVARD, INCLINE VILLAGE NV 89451 |
Dominique Monnet | officer: President and CEO | C/O ALEXION PHARMACEUTICALS, INC., 352 KNOTTER DRIVE, CHESHIRE CT 06410 |
Christopher Lewis Stone | officer: VP, Gen. Counsel & Secretary | 932 SOUTHWOOD BLVD. INCLINE VILLAGE NV 89451 |
Alan Lee Bazaar | director | 9 BEDFORD ROAD, KATONAH NY 10536 |
Natasha Hernday | director | 932 SOUTHWOOD BLVD, INCLINE VILLAGE NV 89451 |
Edward Imbrogno | officer: VP Finance, CAO and Acting CFO | 932 SOUTHWOOD BLVD. INCLINE VILLAGE NV 89451 |
Jill M. Jene | officer: VP, Business Development | 932 SOUTHWOOD BLVD., INCLINE VILLAGE NV 89451 |
Harold E Selick | director | |
Samuel R Saks | director | 3180 PORTER DRIVE, PALO ALTO CA 94304 |
Paul W Sandman | director | C/O PDL BIOPHARMA, INC., 932 SOUTHWOOD BLVD, INCLINE VILLAGE NV 89451 |
Shlomo Yanai | director | ONE MEADOWLANDS PLAZA, EAST RUTHERFORD NJ 07073 |
Peter S Garcia | officer: Vice President, CFO | ALX ONCOLOGY HOLDINGS INC., 866 MALCOLM ROAD, SUITE 100, BURLINGAME CA 94010 |
Jody S Lindell | director | 2536 FILLMORE ST., SAN FRANCISCO CA 94115 |
Paul R Edick | director | C/O NEWLINK GENETICS CORP., 2503 SOUTH LOOP DR., SUITE 5100, AMES IA 50010 |
From GuruFocus
By PRNewswire PRNewswire • 11-14-2019
By PRNewswire PRNewswire • 12-10-2019
By PRNewswire PRNewswire • 04-30-2020
By PRNewswire PRNewswire • 12-03-2019
By PRNewswire PRNewswire • 12-09-2019
By GuruFocus Research GuruFocus Editor • 11-04-2020
By GuruFocus Research GuruFocus Editor • 12-17-2020
By PRNewswire PRNewswire • 08-31-2020
By PRNewswire PRNewswire • 12-13-2019
By PRNewswire PRNewswire • 10-29-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.